本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pyxis Oncology, Inc.

2.61
-0.0700-2.61%
成交量:85.54萬
成交額:230.33萬
市值:1.65億
市盈率:-2.00
高:2.83
開:2.72
低:2.60
收:2.68
52周最高:5.55
52周最低:0.9700
股本:6,335.55萬
流通股本:4,913.47萬
量比:0.75
換手率:1.74%
股息:- -
股息率:- -
每股收益(TTM):-1.3026
每股收益(LYR):-1.2813
淨資產收益率:-121.66%
總資產收益率:-51.94%
市淨率:5.29
市盈率(LYR):-2.04

資料載入中...

公司資料

公司名字:
Pyxis Oncology, Inc.
交易所:
NASDAQ
成立時間:
2018
員工人數:
56
公司地址:
321 Harrison Avenue,11th Floor, Suite 1,Boston,Massachusetts,United States
郵編:
02118
電話:
傳真:
- -
簡介:
Pyxis Oncology, Inc.於2018年6月11日在特拉華州註冊成立。該公司是一家臨床階段的腫瘤學公司,推進專註於解決實體瘤患者未滿足的醫療需求的發展戰略,並立即關注頭頸部鱗狀細胞癌(HNSCC)。

董事

名稱
職位
John Flavin
Chairman of the Board
Lara Sullivan
Chief Medical Officer, Chief Executive Officer, President and Director
Darren Cline
Independent Director
Freda Lewis Hall
Independent Director
Jakob Dupont
Independent Director
Michael A. Metzger
Independent Director
Rachel Humphrey
Independent Director
Santhosh Palani
Independent Director
Thomas Civik
Independent Director

股東

名稱
職位
Lara Sullivan
Chief Medical Officer, Chief Executive Officer, President and Director
Jitendra Wadhane
Principal Financial Officer and Chief Accounting Officer